Drug intelligence / Profile preview

APOPROSTAT forte

Development stage
Unknown
Lead developer
APOGEPHA Arzneimittel
Modality
Small Molecules
Administration
Oral
01

Overview

APOPROSTAT forte is a herbal urological medication developed and marketed by Apogepha Arzneimittel GmbH for the symptomatic treatment of benign prostatic hyperplasia (BPH). The active ingredient is a phytosterol complex (65 mg per capsule, containing at least 70% β-sitosterol) extracted from maritime pine bark (*Pinus pinaster*). It is indicated for mild to moderate lower urinary tract symptoms (LUTS) associated with BPH, such as frequent urination, nocturia, and weak urinary stream. The drug exerts its effects through multiple mechanisms, including anti-inflammatory activity, modulation of growth factors in prostate cells, and reduction of edema (water retention) in the prostate tissue. It is available as an over-the-counter (OTC) medication in Germany and represents the highest phytosterol concentration available on the German market for LUTS/BPH treatment.

Brand names
APOPROSTAT forte
Other names
phytosterolbeta-sitosterolPinus pinaster bark extract
02

Targets

ADRA1A (α1A)

Beyond the preview

Go deeper on APOPROSTAT forte.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on APOPROSTAT forte.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call